Pembrolizumab in Intermediate Risk Recurrent Non-muscle Invasive Bladder Cancer (NMIBC)
Clinical trial NCT03167151 · TERMINATED
Trial details
- NCT number
- NCT03167151
- Sponsor
- University of Oxford
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-03-02
- Primary completion
- 2019-03-26
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.